Erythropoietin: Physiologic and pharmacologic aspects

Proceedings of the Society for Experimental Biology and Medicine

Volumn 216, Issue 3, 1997, Pages 358-369

  Fisher, James W ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Society for Experimental Biology and Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ZIDOVUDINE;

ANEMIA; BLOOD AUTOTRANSFUSION; BONE MARROW; CANCER CHEMOTHERAPY; COLONY FORMING UNIT E; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIESIS; HORMONE ACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY; KIDNEY FAILURE; LIVER; MOLECULAR WEIGHT; MYELODYSPLASIA; PREMATURITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; RHEUMATOID ARTHRITIS; SHORT SURVEY; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS; MAMMALIA;

EID: 0030734731     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44183     Document Type: Short Survey

References (154)

1. Carnot C, DeFlandre C. Sur l'activité hémopoiétique du sérum au cours de la régénération du sang. CR Acad Sci Paris 143:432-435, 1906.
2. Hjort E. Reticulocyte increase after injection of anemic serum. Norsk Mag F Laegevidensk 97:270-277, 1936.
3. Krumdieck N. Erythropoietic substance in the serum of anemic animals. Proc Soc Exp Biol Med 54:14-17, 1943.
4. Erslev A. Humoral regulation of red cell production. Blood 8:349-357, 1953.
5. Bondsdorff E, Jalavisto E. A humoral mechanism in anoxic erythrocytosis. Acta Physiol Scand 16:150-170, 1948.
6. Reissmann KR. Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. Blood 5:372-380, 1950.
7. Jacobson LO, Goldwasser E, Fried W, Ptzak L. Role of the kidney in erythropoiesis. Nature 179:633-634, 1957.
8. Fisher JW, Birdwell BJ, The production of an erythropoietic factor by the in situ perfused kidney. Acta Haematol 26:224-232, 1961.
9. Kuratowska Z, Lewartowski B, Michalak E. Studies on the production of erythropoietin by isolated perfused organs. Blood 18:527-534, 1961.
10. Nathan DG, Schupak E, Stohlman F Jr., Merril JP. Erythropoiesis in anephric man. J Clin Invest 43:2158-2165, 1964.
11. Miyake T, Kung CKH, Goldwasser E. Purification of human erythropoietin. J Biol Chem 252:5558-5564, 1977.
12. Jacobs K, Shoemaker C, Rudersdorf R, Neill SD, Kaufman RJ, Mufson A, Seehra J, Jones SS, Hewick R, Fritsch EF, Kawakita M, Shimizu T, Miyake T. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313:806-810, 1985.
13. Lin F-K, Suggs S, Lin C-H, Browne JK, Smalling R, Egrie JC, Chen KK, Fox GM, Martin F, Wasser Z. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A 82:7850-7584, 1985.
14. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 316:73-78, 1987.
15. Lai P-H, Everett R, Wang FF, Arakawa T, Goldwasser E. Structural characterization of human erythropoietin. J Biol Chem 261:3116-3121, 1986.
16. Jelkman W. Erythropoietin structure, control of production, and function. Physiol Rev 72:449-489, 1992.
17. Davis JM, Arkawa T, Strickland TW, Yphantis DA. Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells. Biochemistry 26:2633-2638, 1987.
18. Broudy VC, Tait JF, Powell JS. Recombinant human erythropoietin: Purification and analysis of carbohydrate linkage. Arch Biochem Biophys 265:329-336, 1988.
19. Egrie JC, Strickland TW, Lane J, Aoki K, Cohen AM, Smalling R, Trail G, Lin FK, Browne JK, Hines DK. Characterization and biological effects of recombinant human erythropoietin. Immunobiology 172:213-224, 1986.
20. Sasak H, Bothner B, Deli A, Fukuda M. Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J Biol Chem 262:12059-12076, 1987.
21. Takeuchi M, Inoue N, Strickland TW, Kubota M, Wada M, Shimizu R, Hoshi S, Kozutsumi H, Takasaki S, Kobata A. Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells. Proc Natl Acad Sci U S A 86:7819-7822, 1989.
22. Dordal MS, Wang FF, Goldwasser E. The role of carbohydrate in erythropoietin action. Endocrinology 116:2293-2299, 1985.
23. Lukowsky WA, Painter RH. Studies on the role of sialic acid in the physical and biological properties of erythropoietin. Can J Biochem 50:909-917, 1972.
24. Tsuda E, Kawanishi G, Ueda M, Masuda S, Sasaki R. The role of carbohydrate in recombinant human erythropoietin. Eur J Biochem 188:405-411, 1990.
25. Goto M, Murakami A, Akai K, Kawanishi G, Ueda M, Chiba H, Sasaki R. Characterization and use of monoclonal antibodies directed against human erythropoietin that recognize different antigenic determinants. Blood 74:1415-1423, 1989.
26. Ma DDF, Wei A-Q, Dowton LA, Lau KS, Wu Z-H, Ueda M. Assessment of an EIA for measuring human serum erythropoietin as compared with RIA and an in-vitro bioassay. Br J Haematol 80:431-436, 1992.
27. Sakata S, Enoki Y, Shimizu S, Hattori M, Ueda M. Correlation between a sandwich ELISA and an in-vitro bioassay for erythropoietin in human plasma. Br J Haematol 91:562-565, 1995.
28. Mason-Garcia M, Beckman BS, Brookins JW, Powell JS, Lanham W, Blaisdell S, Keay L, Li S-C, Fisher JW. Development of a new radioimmunoassay for erythropoietin using recombinant erythropoietin. Kidney Int 38:969-975, 1990.
29. Egrie JC, Cotes PM, Lane J, Gaines RE, Das Tarry RC. Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods 99:235-241, 1987.
30. Sherwood JB, Goldwasser E. A radioimmunoassay for erythropoietin. Blood 54:885-893, 1979.
31. Wide L, Bengtsson C, Birgegard G. Circadian rhythm of erythropoietin in human serum. Br J Haematol 72:85-90, 1988.
32. McGonigle RJS, Boineau F, Beckman B, Frempong KO, Levy J, Shadduck RK, Fisher JW. Erythropoietin and inhibitors of in vivo erythropoiesis in the development of anemia in children with renal disease. J Lab Clin Med 105:449-158, 1985.
33. Zanjani ED, Poster J, Burlington H, Mann LI, Wasserman LR. Liver as the primary site of erythropoietin production in the fetus. J Lab Clin Med 89:640-644, 1977.
34. Zanjani ED, Ascensao JL, McGlave PB, Banisadre M, Ash RC. Studies on the liver to kidney switch of erythropoietin production. J Clin Invest 67:1183-1188, 1981.
35. Denny WF, Flanigan WF, Zukoski CF. Serial erythropoietin studies in patients undergoing renal homotransplantation. J Lab Clin Med 67:386-397, 1966.
36. Bondurant MC, Koury MJ. Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol Cell Biol 6:2731-2733, 1986.
37. Koury ST, Bondurant MC, Cairo J, Garber SE. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: Correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 74:645-651, 1989.
38. Koury ST, Bondurant MC, Koury MJ, Semenza GL. Localization of cells producing erythropoietin in murine liver by in situ hybridization. Blood 77:2497-2503, 1991.
39. Lacombe C, DaSilva J-L, Bruneval P, Fournier J-G, Wendung F, Casadevall N, Camilleri J-P, Bariety J, Varet B, Tambourin P. Pertibular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest 81:620-623, 1988.
40. Semenza GL, Koury ST, Nejfelt MK, Gearhart JD, Antonarakis SE. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci U S A 88:8725-8729, 1991.
41. Loya F, Yang Y, Lin H, Goldwasser E, Alsitar M. Transgenic mice carrying the erythropoietin gene promoter linked to lacZ express the reporter in proximal convoluted tubule cells after hypoxia. Blood 84:1831-1836, 1994.
42. Maxwell AP, Lappin TRJ, Johnston CF, Bridges JM, McGeown MG. Erythropoietin production in kidney tubular cells. Br J Haematol 74:534-539, 1990.
43. Fisher JW, Koury S, Ducey T, Mendel S. Erythropoietin (Epo) production by interstitial cells of hypoxic monkey kidneys. Br J Haematol 95:27-32, 1996.
44. Bachmann S, LeHir M, Eckardt K-U. Co-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 41:335-341, 1993.
45. Maxwell PH, Osmond MK, Pugh CW, Hereyet A, Tan CC, Doe BG, Ferguson DJ, Johnson MH, Radcliffe PJ. Identification of the renal erythropoietin producing cells using transgenic mice. Kidney Int 44:1149-1162, 1993.
46. Semenza GL. Regulation of erythropoietin production - New insights into molecular mechanisms of oxygen homeostasis. In: Spivak JL, Ed. Hematology/Oncology, Clinics of North America. Erythropoietin: Basic and Clinical Aspects. Philadelphia: W. B. Saunders, Vol 8:p863-884, 1994.
47. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90:4304, 1993.
48. Clemons GK, Fitzsimmons SL, Demanincor D. Immunoreactive erythropoietin concentrations in fetal and neonatal rats and the effects of hypoxia. Blood 68:892-899, 1986.
49. Lucarelli G, Porcellini A, Carnevali C, Carmena A, Stohlman F. Fetal and neonatal erythropoiesis. Ann NY Acad Sci 149:544-559, 1968.
50. Ueno M, Seferynska I, Beckman B, Brookins J, Nakashima J, Fisher JW. Enhanced erythropoietin secretion in hepatoblastoma cells in response to hypoxia. Am J Physiol 257(Cell Physiol 26):C743-C749, 1989.
51. Naskashima J, Ohigashi T, Brookins J, Beckman B, Agrawal K, Fisher JW. Effects of S-N-ethylcarboxamideadenosine (NECA) on erythropoietin production. Kidney Int 44:734-740, 1993.
52. 2 receptor moduation of erythropoietin secretion in hepatocellular carcinoma cells. Life Sci 54:109-117, 1993.
53. Nagashima K, Karasawa A. Modulation of erythropoietin production by selective adenosine agonists and antagonists in normal and anemic rats. Life Sci 59:761-771, 1996.
54. Ohigashi T, Brookins J, Fisher JW. Interaction of nitric oxide and cyclic guanosine 3′-5′-monophosphate in erythropoietin production. J Clin Invest 92:1587-1591, 1993.
55. Yoshioka K, Fisher JW. Nitric oxide enhancement of erythropoietin production in the isolated perfused rat kidney. Am J Physiol (Cell Physiol) 38:C919-C922, 1995.
56. Ohigashi T, Yoshioka K, Fisher JE. Autocrine regulation of erythropoietin gene expression in human hepatocellular carcinoma cells. Life Sci 58:421-427, 1996.
57. Jelkmann W, Huwiler A, Fandrey J, Pfeils-Chifter J. Inhibition of erythropoietin production by phorbol ester is associated with downregulation of protein kinase C-α isoenzyme in hepatoma cells. Biochem Biophys Res Commun 179:1441-1448, 1991.
58. Ueno M, Brookins J, Beckman BS, Fisher JW. Effects of reactive oxygen metabolites on erythropoietin production in renal carcinoma cells. Biochem Biophys Res Commun 154:773-780, 1988.
59. Goldberg MA, Dunning SP, Bunn HF. Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein. Science 242:1412-1415, 1988.
60. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature 380:221-226, 1996.
61. Hunter T, Karin M. The regulation of transcription by phosphorylalion. Cell 70:375-387, 1992.
62. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12:5447, 1992.
63. Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 268:21513-21518, 1993.
64. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci U S A 88:5680-5684, 1991.
65. Fandrey J, Frede S, Jelkmann W. Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem J 303:507-510, 1994.
66. Wolin MS. Reactive oxygen species and vascular signal transduction mechanisms. Microcirculation 3:1-17, 1996.
67. 2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Nat Acad Sci U S A 86:6758-6762, 1989.
68. Sawyer ST, Hankins WD. The functional form of the erythropoietin receptor is a 78-kDa protein: Correlation with cell surface expression, endocytosis, and phosphorylation. Proc Nat Acad Sci USA 90:6849-6853, 1993.
69. Youssoufian H, Longmore G, Newmann D, Yoshimura A, Lodish H. Structure, function and an activation of erythropoietin receptor. Blood 81:223-236, 1993.
70. Sawyer ST, Penta K. Association of JAK2 and STAT5 with erythropoietin receptors. J Biol Chem 271:32430-32437, 1996.
71. D'Andrea AD, Lodish HF, Wong GG. Expression cloning of the murine erythropoietin receptor. Cell 57:277-285, 1989.
72. Sawada K, Krantz SB, Kans JS, Dessypris EN, Sawyer S, Glick AD, Civin CI. Purification of human colony-forming units-erythroid and demonstration of specific binding of erythropoietin. J Clin Invest 80:357-366, 1987.
73. Sawada K, Krantz SB, Dai C-H, Koury ST, Horn ST, Glick AD, Civin CI. Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol 142:219-230, 1990.
74. Sawyer ST, Koury MJ. Erythropoietin requirement during terminal erythroid differentiation: The role of surface receptors for erythropoietin. (abstract) J Cell Biol 105:1077, 1987.
75. Sawyer ST. Receptors for erythropoietin. Distribution, structure, and role in receptor-mediated endocytosis in erythroid cells. In: Harris Jr, Ed. Blood Cell Biochemistry. New York: Plenum, Vol. I:pp365-402, 1990.
76. Sawyer ST, Krantz SB, Goldwasser E. Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells. J Biol Chem 262:5554-5562, 1987.
77. Sakaguchi M, Koishihara Y, Tsuda H, Fujimoto K, Shibuya K, Kawakita M, Takatsuki K. The expression of functional erythropoietin receptors on an interleukin-3 dependent cell line. Biochem Biophys Res Commun 146:7-12, 1987.
78. Sawyer ST, Penta K. Erythropoietin cell biology. In: Spivak JL, Ed. Hematology/Oncology Clinics of North America. Erythropoietin: Basic and Clinical Aspects, Vol 6:pp895-911, 1994.
79. Dusanter-Fourt I, Casadevall N, Lacombe C, Muller O, Billat C, Fischer S, Mayeux P. Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. J Biol Chem 267:10670-10675, 1992.
80. Mayeux P, Lacombe C, Casadevall N. Structure of the murine erythropoietin receptor complex. J Biol Chem 266:23380-23385, 1991.
81. Miura O, D'Andrea A, Kabat D, IhIe JN. Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol Cell Biol 11:4895-4902, 1991.
82. Yoshimura A, D'Andrea AD, Lodish H. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc Natl Acad Sci U S A 87:4139-4143, 1990.
83. Spangler R, Sytkowski AS. C-myc is an early erythropoietin response gene in normal erythroid cells: Evidence for a protein kinase C-mediated signal. Blood 79:52-57, 1992.
84. Krantz SB. Erythropoietin. Blood 77:419-434, 1991.
85. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378-381, 1990.
86. Koury MJ. Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 20:391-394, 1994.
87. Dessypris EN, Gleaton JH, Armstrong OL. Effect of human recombinant erythropoietin on human marrow megakaryocyte colony formation in vitro. Br J Haematol 65:265-269, 1987.
88. Wu H, Klingmuller U, Besmer P, Lodish HF. Interaction of the erythropoietin and stem-cell-factor receptors. Nature 377:242-246, 1995.
89. Jacobs-Helber SM, Penta K, Sun Z, Lawson A, Sawyer ST. Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J Biol Chem 272:6850-6853, 1997.
90. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-236, 1993.
91. Zhuang H, Patel SV, He T-C, Sonsteby SK, Niu Z, Wojchowski DM. Inhibition of erythropoietin induced mitogenesis by a kinase-deficient form of JAK2. J Biol Chem 269:21411-21414, 1994.
92. Adunyah S, Evans K, Ceesay J, Rivero JA. Regulation of jun expression and activations of AP-1 activity by erythropoietin. Biochem Biophys Res Commun 221:213-218, 1996.
93. Wako H, Harada N, Kitamura T, al-F Mui, Miyajima A. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J 14:2527-2535, 1995.
94. Penta K, Sawyer ST. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells. J Biol Chem 270:31282-31287, 1995.
95. Damen JE, Wakao H, Miyajima A, Krosl J, Humphries R, Cutler RL, Krystal K. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin induced cell proliferation and STAT5 activation. EMBO J 14:5557-5568, 1995.
96. Sawyer ST, Penta K. Association of JAK2 and STAT5 with erythropoietin receptors. J Biol Chem 271:32430-32437, 1996.
97. Chin H, Nakamura N, Kamiyama N, Miyasaka J, Ihle N, Miura O. Physical and functional interactions between stat 5 and tyrosine-phosphorylated receptors for erythropoietin and interleukin-3. Blood 88:4415-1425, 1996.
98. Ihle NN. STATS: Signal transducers and activators of transcription. Cell 84:331-334, 1996.
99. IhIe JN, Kerr IM. JAK5 and STAT5 in signaling by the cytokine receptor superfamily. Trends Genet 11:69-74, 1995.
100. Todokoro K, Sugiyama M, Nishida E, Nakaya K. Activation of mitogen-activated protein kinase cascade through erythropoietin receptor. Biochem Biophys Res Commun 203:1912-1919, 1994.
101. Yi T, Mui AL-F, Krystal G, Ihle JN. Hematopoietic cell phosphatase associates with the InterIeukin-3 (IL-3) receptor β chain and down regulates IL-3 induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 13:7577-7586, 1993.
102. D'Andrea AD, Yoshimura H, Zon LI, Koo JW, Lodish HF. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol 11:1980-1987, 991.
103. Carroll MP, Spivak JL, McMahon M, Weich N, Rapp VR, May WS. Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliveration. J Biol Chem 266:14964-14969, 1991.
104. Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G. The 145-kDa protein induced to associate with She by multiple cytokines is an inositol tetraphosphate and phosphotidylinositol 3,4,5-trisphosphate 5-phosphatase. Proc Nat Acad Sci U S A 93:1689-1693, 1996.
105. Barber DL, Corless CN, Xia K, Roberts TM, D'Andrea AD. Erythropoietin activates Rafl by Au Shc-independent pathway in CTLL-Epo-R cells. Blood 89:55-64, 1997.
106. Barber DL, Mason JM, Fukazawa T, Reedquist KA, Druken BA, Band H, D'Andrea AD. Erythropoietin and interleukin-3 activate tyrosine phosphorylation and CBL and association with CRK adaptor proteins. Blood 89:3166-3174, 1997.
107. Clejan S, Mallia C, Vinson D, Dotson R, Beckman BS. Erythropoietin stimulates G-protein coupled phospholipase D in haematopoietic target cells. Biochem J 314:853-860, 1996.
108. Peshori SL, Abdel-Mageed AB, Agrawal KC. Enhanced expression of metallothionein gene associated with erythropoietin-induced proliferation and differentiation. Proc Am Assoc Cancer Res 36:46, 1995.
109. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR. Recombinant human erythropoietin in anemic patients with endstage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 111:992-1000, 1989.
110. Henry DH, Beal GN, Benson CA, Cary J, Cone LA. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and Ziduodine therapy. Ann Intern Med 117:739-748, 1992.
111. Müller CB, Platanais LC, Mills SR, Zahurak ML, Ratain MJ, Ettinger DS, Jones RJ. Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia. J Natl Cancer Inst 84:98-103, 1992.
112. Ten Bokkel Huinink WW. Controlled multicenter study of the influence of two different dosages of subcutaneous rhEPO on the development of anemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based combination chemotherapy. In: Smyth JF, Boogaerts MA, Ehmer BRM, Eds. rh-Erythropoietin in Cancer Supportive Treatment. New York: Marcel Dekker, pp 99-112, 1996.
113. Pincus T, Olsen NJ, Russel IJ, Eolfe F, Harms RE. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 89:161-168, 1990.
114. Messer J, Haddad J, Donato L, Astruc D, Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 92:519-523, 1993.
115. Bader D, Blondhein O, Jonas R, Admoni O, Abend-Winger M, Reich D, Lanis A, Tamir A, Eldar T, Attias D. Decreased ferritin levels despite iron supplementation, and during therapy in the anemia of prematurity. Acta Paediatr 85:496-501, 1996.
116. Steegman JL, Lopez J, Otero MJ, Lamana ML, de la Cámara R, Barberana M, Diaz A, Ferńandeź-Ranada JM. Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: Results of a prospective controlled randomized trial. Bone Marrow Transplant 10:541-546, 1992.
117. Pierelli L, Scambia G, Menichella G, d'Onofrio G, Salerno G, Panici PB, Foddai ML, Vittori M, Lai M, Ciarli M, Puglia G, Mancuso S, Bizzi B. The combination of erythropoietin and granulocyte colony-stimulating factor increases the rate of haemopoietic recovery with clinical benefit after peripheral blood progenitor cell transplantation. Br J Haematol 92:287-294, 1996.
118. Di Raimondo F, Longo G, Cacciola EJR, Milone G, Palumbo GA, Cacciola RR, Alessi M, Giustolisi R. A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study. Eur J Haematol 56:7-11, 1996.
119. Faris PM, Ritter MA, Abels RI. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. J Bone Joint Surg 78-A: 62-72, 1996.
120. Thomas MJG, Gillon J, Desmond MJ. Preoperative autologous donation. Transfusion 36:633-639, 1996.
121. Matsumoto K, Hukuda S, Ishizawa M, Chano T, Okabe H. Use of preoperative autologous blood donations and erythropoietin for treatment of giant cell tumor of the ischium. Clin Orthopaed Rel Res 326:246-249, 1996.
122. Price TR, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MFM, Bolgiano DC, Abels RI. The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: A multicenter, randomized, double-blind, controlled trial. Transfusion 36:29-31, 1996.
123. Harris SA, Payne G Jr., Putman JM. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy. Obstet Gynecol 87:812-814, 1996.
124. Goodnough LT, Anderson KC, Kurtz S, Lane TA, Pisciotto PT, Silverstein LE. Indications and guidelines for the use of hematopoietic growth factors. Committee Report. Transfusion 33:944-959, 1993.
125. Adamson JW, Eschbach JW. The use of recombinant human erythropoietin (RHUEPO) in humans. Cancer Surv 9:157-167, 1990.
126. Eschbach JW, Adamson JW. Guidelines for recombinant human erythropoietin therapy. Am J Kidney Dis 14(Suppl 1):2-8, 1989.
127. Abraham PA, Macres MG. Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. J Am Soc Nephrol 2:927-936, 1991.
128. Korbet SM. Anemia and erythropoietin in hemodialysis and continuous ambulatory periotoneal dialysis. Kidney Int 43(Suppl 40):111-119, 1993.
129. Beccari M. Seizures in dialysis patients with recombinant erythropoietin: Review of the literature and guidelines for prevention. Int J Artif Organsa 17:5-13, 1994.
130. Heidenreich S, Rahn K-H, Zidek W. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 39:259-265, 1991.
131. Gill ML, Anderton JL. Erythropoietin-induced hypertension without raising haematocrit. Nephrol Dial Transplant 8:1264-1266, 1993.
132. Maschio G. Erythropoietin and systemic hypertension. Nephrol Dial Transplant 10[Suppl. 2]:74-79, 1995.
133. Raine AEG. Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: Implications of erythropoietin therapy. Lancet 1:97-100, 1988.
134. Neff MS, Kim KE, Persoff M, Onesti G, Swartz C. Hemodynamics of uremic anemia. Circulation 63:876-883, 1971.
135. Nonnast-Danie B, Schaffer J, Frei U. Hemodynamics in hemodialysis patients treated with recombinant human erythropoietin. Contrib Nephrol 76:283-291, 1989.
136. Tepel M, Wischinowski H, Zidek W. Erythropoietin increases cytosolic free calcium concentration and thrombin induced changes in cytosolic free calcium in platelets from spontaneously hypertensive rats. Biochem Biophys Res Commun 177:991-997, 1991.
137. Sawyer ST, Krantz SB. Erythropoietin stimulates 45 Ca uptake in friend virus-infected erythroid cells. J Biol Chem 259:2769-2774, 1984.
138. Anagonstou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT. Erythropoietin receptor m RNA expression in human endothelial cells. Proc Natl Acad Sci U S A 91:3974-3978, 1994.
139. Carlini RG, Gupta A, Liapis H, Rothstein M. Endothelin-1 release by erythropoietin involves calcium signaling in endothelial cells. J Cardiovasc Pharmacol 26:889-892, 1995.
140. Buemi M, Morabito M, Palella S, Allegra A, Frisina N, Gemelli M, Manganaro R, Stelitano L, Palmara A. Influence of recombinant erythropoietin on the production of endothelin-1 from human umbilical artery. Nephron 64:165-166, 1993.
141. Yamashita W, Kamizono A, Ohasi T, Harada R, Arima T. Recombinant human erythropoietin induces high plasma endothelin levels in hemodialysis patients. J Am Soc Nephrol 1:409A, 1991.
142. Carlini RG, Reyes A, Rothstein M. Human recombinant erythropoietin stimulates angiogenesis in vitro. Kidney Int 9:650-654, 1994.
143. Gogusey J, Zhu DL, Herembert T, Ammarguellat F, Marche P, Drueke T. Effect of erythropoietin on DNA synthesis, protooncogene expression and phospholipase C activity in rat vascular smooth muscle cells. Biochem Biophys Commun 199:977-983, 1994.
144. Van Geet C, Hauglustaine D, Verresen L, Vanrusselt M, Vermylen J. Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients. Thromb Haemost 61:;117-121, 1989.
145. Roger SD, Piper J, Tucker B, Raine AEG, Baker LRI, Kovacs IB. Enhanced platelet reactivity with erythropoietin but not following transfusion in dialysis patients. Nephrol Dial Transplant 8:213-217, 1993.
146. Caravaca F, Pizarro JL, Arrobas M, Cubero JJ, Garcia MC, Perez-Miranda M. Anti-platelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patients. Kidney Int 45:845-851, 1994.
147. Sobota JT. An International Perspective. Garnick MC, Ed. New York: Marcel Dekker, 1990.
148. Fisher JW. Recent advances in erythropoietin research. In: Jucker E, Ed. Progress in Drug Research. Boston: Birkhauser Verlag, Vol 41:pp293-311, 1993.
149. Tervel JL, Marcen R, Navarro-Antolin J, Aguislera A, Fernandez-Juarcz G, Ortuno J. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: A protective study. J Am Soc Nephrol 7:140-144, 1996.
150. Fischl M, Galpin JF, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W, Starrett B, Zalusky R, Abels RI, Tsai HC, Rudnick SA. Recombinant human erythropoietin for patients with aids treated with zidovudine. N Engl J Med 322:1488-1493, 1990.
151. Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 261:3104-3107, 1989.
152. Bakris GR, Sauter ER, Hussey JL, Fisher JW, Gaber AO, Winsett R. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. N Engl J Med 323:86-90, 1990.
153. Grekas D, Dioudis C, Valkouma D, Papoulidou F, Tourkantonis A. Theophylline modulates erythrocytosis after renal transplantation. Nephron 70:25-27, 1995.
154. Ilan Y, Dranitzki-Elhallel M, Rubinger D, Silver J, Popvtzer MM. Erythrocytosis after renal transplantation. Transplantation 57:661-664, 1994.